Search - tctmd.com

Displaying 161 - 180 of 211

Sort: Relevancy | Date

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

News Industry News

CardiAQ™ Valve Technologies, Inc. announces that it has obtained a stay of further proceedings in Neovasc Inc.’s pending European patent application covering Transcatheter Mitral Valve Replacement

July 07, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Daily News

Se Observa Cierto Empeoramiento a Largo Plazo en los Resultados Favorables de una Serie Inicial de CoreValve

July 03, 2014

News Industry News

Thoratec Acquires Apica Cardiovascular

July 02, 2014

News Industry News

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

June 06, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Industry News

CardiAQ™ Valve Technologies reports Successful

May 20, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

L.A. McKeown

March 13, 2014

News Daily News

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

L.A. McKeown

March 13, 2014

News Daily News

Preclinical Data Show Safety, Efficacy of Transcatheter Mitral Valve

Yael L. Maxwell

January 22, 2014

News Daily News

Los Datos Preclínicos Confirman la Seguridad y Eficacia de la Válvula Mitral Transcatéter

Yael L. Maxwell

January 22, 2014

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Presenter: Andreas R?ck

October 29, 2013

Advertisement

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

CardiAQ™ Valve Technologies, Inc. announces that it has obtained a stay of further proceedings in Neovasc Inc.’s pending European patent application covering Transcatheter Mitral Valve Replacement

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

Se Observa Cierto Empeoramiento a Largo Plazo en los Resultados Favorables de una Serie Inicial de CoreValve

Thoratec Acquires Apica Cardiovascular

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

CardiAQ™ Valve Technologies reports Successful

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

Preclinical Data Show Safety, Efficacy of Transcatheter Mitral Valve

Los Datos Preclínicos Confirman la Seguridad y Eficacia de la Válvula Mitral Transcatéter

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Innovation in Intervention: Perspectives from Industry

TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content